Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.84
-0.43 (-3.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Trevi Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-42.76-47.91-29.07-29.15-33.94
Upgrade
Depreciation & Amortization
0.140.150.120.040.05
Upgrade
Other Amortization
0.03-0.570.520.6
Upgrade
Loss (Gain) From Sale of Assets
0.01-0.01--
Upgrade
Loss (Gain) From Sale of Investments
-1.64-1.37-2.13-0.83-
Upgrade
Stock-Based Compensation
5.193.592.252.332.54
Upgrade
Other Operating Activities
0.440.460.380.150.29
Upgrade
Change in Accounts Payable
-0.61.61-1.050.010.83
Upgrade
Change in Other Net Operating Assets
-2.895.22-2.8-1.240.68
Upgrade
Operating Cash Flow
-42.09-38.26-31.71-28.18-28.95
Upgrade
Capital Expenditures
-0.01-0.04-0.14-0.16-
Upgrade
Investment in Securities
-94.1-21.4959.57-107.21-
Upgrade
Investing Cash Flow
-94.11-21.5359.43-107.37-
Upgrade
Long-Term Debt Repaid
-0.01-0.13-9.5-5.83-
Upgrade
Net Debt Issued (Repaid)
-0.01-0.13-9.5-5.83-
Upgrade
Issuance of Common Stock
121.1161.611.85117.4321.23
Upgrade
Other Financing Activities
-0.08--0.26-0.29-0.45
Upgrade
Financing Cash Flow
121.0161.48-7.91111.3120.78
Upgrade
Net Cash Flow
-15.181.719.81-24.24-8.17
Upgrade
Free Cash Flow
-42.1-38.29-31.85-28.33-28.95
Upgrade
Free Cash Flow Per Share
-0.31-0.38-0.32-0.44-1.27
Upgrade
Cash Interest Paid
-00.330.590.6
Upgrade
Levered Free Cash Flow
-27.86-21.03-21.97-17.95-16.5
Upgrade
Unlevered Free Cash Flow
-27.86-21.03-21.91-17.74-16.35
Upgrade
Change in Working Capital
-3.496.83-3.85-1.231.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.